The end of the COVID-19 Public Health Emergency ended mandatory reporting of device shortages, but the US Food and Drug Administration encourages manufacturers to continue to alert the agency regardless.
Section 506J of the Food, Drug and Cosmetics Act requires manufacturers to report shortages of critical devices during (or in advance of) a public health emergency
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?